Daming Gao

9.0k total citations · 1 hit paper
77 papers, 3.8k citations indexed

About

Daming Gao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Daming Gao has authored 77 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 25 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Daming Gao's work include Ubiquitin and proteasome pathways (29 papers), Cancer-related Molecular Pathways (15 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Daming Gao is often cited by papers focused on Ubiquitin and proteasome pathways (29 papers), Cancer-related Molecular Pathways (15 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Daming Gao collaborates with scholars based in China, United States and Japan. Daming Gao's co-authors include Wenyi Wei, Hiroyuki Inuzuka, Lixin Wan, Shavali Shaik, Alan Tseng, Hidefumi Fukushima, Alan W. Lau, Pengda Liu, Steven P. Gygi and Alex Toker and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Daming Gao

74 papers receiving 3.8k citations

Hit Papers

SCFFBW7 regulates cellular apoptosis by targeting MCL1 fo... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daming Gao China 34 3.0k 1.2k 645 551 393 77 3.8k
Lixin Wan United States 37 3.5k 1.2× 1.3k 1.1× 746 1.2× 783 1.4× 355 0.9× 66 4.3k
Zhenguo Wu Hong Kong 37 3.6k 1.2× 814 0.7× 748 1.2× 502 0.9× 250 0.6× 99 5.0k
Hongquan Zhang China 40 2.8k 0.9× 866 0.7× 952 1.5× 842 1.5× 258 0.7× 146 4.4k
Javier Muñoz Spain 30 2.7k 0.9× 778 0.7× 464 0.7× 422 0.8× 220 0.6× 97 3.8k
Peiqing Sun United States 41 3.6k 1.2× 1.2k 1.0× 991 1.5× 458 0.8× 324 0.8× 84 5.0k
Edward A. Ratovitski United States 37 2.9k 1.0× 1.6k 1.4× 806 1.2× 328 0.6× 296 0.8× 75 4.2k
Feng Cong United States 34 3.8k 1.2× 1.4k 1.2× 408 0.6× 534 1.0× 240 0.6× 64 5.0k
Steven A. Johnsen Germany 42 3.8k 1.3× 1.3k 1.1× 635 1.0× 289 0.5× 253 0.6× 106 4.9k
Julie Guillermet‐Guibert France 26 2.3k 0.8× 956 0.8× 392 0.6× 458 0.8× 524 1.3× 53 3.9k
Christina H. Stuelten United States 24 1.5k 0.5× 880 0.7× 468 0.7× 367 0.7× 306 0.8× 38 3.1k

Countries citing papers authored by Daming Gao

Since Specialization
Citations

This map shows the geographic impact of Daming Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daming Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daming Gao more than expected).

Fields of papers citing papers by Daming Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daming Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daming Gao. The network helps show where Daming Gao may publish in the future.

Co-authorship network of co-authors of Daming Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Daming Gao. A scholar is included among the top collaborators of Daming Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daming Gao. Daming Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ran, Haoran Qian, Xinyu Xie, et al.. (2025). Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression. Cancer Research. 85(7). 1253–1269. 2 indexed citations
2.
Gao, Daming & Judy Wai Ping Yam. (2024). Reversal of lipid metabolism as a therapeutic approach for HCC. Hepatology. 81(4). 1113–1115.
3.
Han, Ying, Huairui Yuan, Qiuli Liu, et al.. (2024). Zinc ions activate AKT and promote prostate cancer cell proliferation via disrupting AKT intramolecular interaction. Oncogene. 44(1). 8–18. 2 indexed citations
4.
Zhu, Hongwen, Youpei Lin, Dayun Lu, et al.. (2023). Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. National Science Review. 10(8). nwad167–nwad167. 21 indexed citations
5.
Luo, Dakui, Min Chen, Qingguo Li, et al.. (2023). CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. Experimental Hematology and Oncology. 12(1). 77–77. 13 indexed citations
6.
Fu, Zhi, et al.. (2023). Comprehensive Analysis of the Sorafenib-Associated Druggable Targets on Differential Gene Expression and ceRNA Network in Hepatocellular Carcinoma. Journal of Environmental Pathology Toxicology and Oncology. 42(4). 47–60. 3 indexed citations
8.
Lin, Wen-Zhen, et al.. (2021). Osteomodulin positively regulates osteogenesis through interaction with BMP2. Cell Death and Disease. 12(2). 147–147. 49 indexed citations
9.
Lin, Dongdong, Zhi Fu, Guang Yang, et al.. (2020). Exportin-5 SUMOylation promotes hepatocellular carcinoma progression. Experimental Cell Research. 395(2). 112219–112219. 18 indexed citations
11.
Li, Long, Ran Chen, Yuxue Zhang, et al.. (2019). SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells. Cancer Research. 79(17). 4387–4398. 24 indexed citations
12.
Gong, Liyan, et al.. (2019). CUL5-SOCS6 complex regulates mTORC2 function by targeting Sin1 for degradation. Cell Discovery. 5(1). 52–52. 11 indexed citations
13.
Takada, Mamoru, Weiguo Zhang, Aussie Suzuki, et al.. (2017). FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A. Cancer Research. 77(18). 4881–4893. 67 indexed citations
14.
Inuzuka, Hiroyuki, Daming Gao, Lydia W.S. Finley, et al.. (2012). Acetylation-Dependent Regulation of Skp2 Function. Cell. 150(1). 179–193. 175 indexed citations
15.
Wang, Zhiwei, Jiateng Zhong, Hiroyuki Inuzuka, et al.. (2012). An Evolving Role for DEPTOR in Tumor Development and Progression. Neoplasia. 14(5). 368–375. 55 indexed citations
16.
Wang, Zhiwei, Daming Gao, Hidefumi Fukushima, et al.. (2011). Skp2: A novel potential therapeutic target for prostate cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1825(1). 11–17. 96 indexed citations
17.
Gao, Daming, Hiroyuki Inuzuka, Hidefumi Fukushima, et al.. (2011). mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTOR. Molecular Cell. 44(2). 290–303. 209 indexed citations
18.
Singh, Amrik, Min Ye, Octavian Bucur, et al.. (2010). Protein Phosphatase 2A Reactivates FOXO3a through a Dynamic Interplay with 14-3-3 and AKT. Molecular Biology of the Cell. 21(6). 1140–1152. 100 indexed citations
19.
Gao, Daming, Lixin Wan, Hiroyuki Inuzuka, et al.. (2010). Rictor Forms a Complex with Cullin-1 to Promote SGK1 Ubiquitination and Destruction. Molecular Cell. 39(5). 797–808. 74 indexed citations
20.
Gao, Daming, Hiroyuki Inuzuka, Alan Tseng, & Wenyi Wei. (2009). Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1. Cell Division. 4(1). 11–11. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026